Radar > 402493

EMS planning to incorporate Hypera Pharma

EMS planeja incorporação da Hypera Pharma

Intel ID : 402493

Target

Bidder

Brazil

Advisors

prospect

Intel ID 402493
Value EUR 614,96m (Approx.)
Native Currency Brazilian Real (BRL)
Exchange Rate:
Date
Country
Geography
Subsector (Old TTR Sectors)
Primary Subsector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary)
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Subsectors (TTRSC)
30.01.01 Biopharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.04 Specialty Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

15.05.08 Food & Beverage Retail
15 Consumer Products & Services / 15.05 Distribution & Retail

10.01.09 Intellectual Property Management Services
10 Business Services / 10.01 Business & Professional Support Services

Type
Intel Grade
Source
Tags

Bidder

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
10.01.09 Intellectual Property Management Services
10 Business Services / 10.01 Business & Professional Support Services

15.05.08 Food & Beverage Retail
15 Consumer Products & Services / 15.05 Distribution & Retail

30.01.01 Biopharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.04 Specialty Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Target

Name
verified
Subsector (Old TTR Sectors)
Services and Distribution / Healthcare, Hygiene, Medical Aesthetics and Cosmetics (Primary)
Primary Sector (TTRSC)
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Secondary Sectors (TTRSC)
30.01.01 Biopharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

30.01.04 Specialty Pharmaceuticals
30 Healthcare / 30.01 Biotechnology & Pharmaceuticals

Country
Website
Description

Financial Advisory

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.